Phenylephrine Hydrochloride + Chlorpheniramine MaleateThird Party Manufacturing in India

Phenylephrine Hydrochloride + Chlorpheniramine Maleate combines a decongestant and an antihistamine to provide comprehensive symptom relief in upper respiratory tract conditions. Phenylephrine Hydrochloride is a selective alpha-1 adrenergic receptor agonist that acts on the smooth muscle of blood vessels in the nasal mucosa. When administered orally, it causes vasoconstriction of dilated arterioles in the nasal passages, reducing blood flow to engorged sinus tissues. This decongestant effect shrinks swollen nasal membranes, opens blocked airways, and restores normal sinus drainage. Unlike pseudoephedrine, Phenylephrine has minimal central nervous system stimulation because it does not readily cross the blood-brain barrier. Chlorpheniramine Maleate is a first-generation alkylamine antihistamine that competitively antagonizes histamine at the H₁ receptor site. By blocking histamine-mediated vasodilation, increased capillary permeability, and sensory nerve stimulation, it effectively suppresses sneezing, rhinorrhea, nasal itching, and ocular symptoms associated with allergic rhinitis and the common cold. Chlorpheniramine also has modest anticholinergic properties that contribute to its drying effect on respiratory secretions. The two agents work synergistically: the antihistamine addresses the allergic-inflammatory component while the decongestant mechanically restores airway patency.

Therapeutic Uses

Phenylephrine Hydrochloride + Chlorpheniramine Maleate is prescribed for the treatment of:

• Allergic Rhinitis (Seasonal and Perennial): The combination effectively manages nasal congestion, sneezing, rhinorrhea, and nasal pruritus triggered by pollen, dust mites, pet dander, and other environmental allergens.
• Common Cold: Provides symptomatic relief from nasal congestion, runny nose, and sneezing associated with viral upper respiratory tract infections.
• Sinusitis: Reduces nasal congestion and promotes sinus drainage in acute and subacute sinusitis cases.
• Nasal Polyposis: Adjunctive therapy for managing congestion symptoms in patients with nasal polyps.
• Otitis Media with Effusion: May help in improving Eustachian tube function through decongestant action.

Why Manufacturers Choose Phenylephrine Hydrochloride + Chlorpheniramine Maleate

This combination represents one of the highest-volume respiratory formulations in the Indian pharmaceutical market, driven by India's year-round allergy season, air pollution in major cities, and high prevalence of viral upper respiratory infections. The multiple strength options (2.5mg, 5mg, and 10mg of Phenylephrine) allow manufacturers to target different patient segments, from paediatric to adult populations. The pellet capsule technology enables taste-masking and controlled release, providing a manufacturing differentiation advantage. Indian WHO-GMP certified facilities can produce this formulation at competitive costs due to the well-established, low-cost API supply chain for both molecules. The product moves in exceptionally high volumes through both the acute prescription market and the OTC segment, making it a staple revenue driver for PCD franchise networks across India. This makes Phenylephrine + Chlorpheniramine one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.